Litcius/Paper detail

Second primary malignancies in patients with haematological cancers treated with lenalidomide: a systematic review and meta-analysis

Kainat Saleem, Joseph Franz, Mary Lou Klem, Jonathan G. Yabes, Michael Boyiadzis, John R Jones, Nader Shaikh, Konstantinos Lontos

2022The Lancet Haematology43 citationsDOIOpen Access PDF

Topics & Concepts

LenalidomideMedicineMultiple myelomaMeta-analysisInternal medicineOncologyRandomized controlled trialThalidomideRelative riskSurgeryConfidence intervalMultiple Myeloma Research and TreatmentsMultiple and Secondary Primary CancersCancer Treatment and Pharmacology